In TAA and AAA, we also noted downregulation of miR-30c-2* which has been shown to participate in cardiac remodeling and fibrosis as a negative regulator of connective tissue growth factor (CTGF), a pro-fibrotic growth factor that promotes deposition of ECM components [25]. This evidence concerns the gene CCN2 and triple-A syndrome.